IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metrikin, D. C.
Right arrow Articles by Peshock, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metrikin, D. C.
Right arrow Articles by Peshock, R. M.

Investigative Ophthalmology & Visual Science, Vol 36, 1361-1370, Copyright © 1995 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis

DC Metrikin, CA Wilson, BA Berkowitz, MK Lam, GK Wood and RM Peshock
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas 75235-9057, USA.

PURPOSE: Endophthalmitis is a severe inflammatory disorder with profound visual consequences. Treatment of this disorder has been limited by the lack of quantitative information regarding retinal responses to severe inflammation. The purpose of this study was to measure the effect of endotoxin-induced endophthalmitis on blood- retinal barrier (BRB) function in vivo using contrast-enhanced magnetic resonance imaging (MRI). METHODS: Endophthalmitis was produced by injecting Escherichia coli endotoxin into the midvitreous of pigmented rabbits. Contrast-enhanced MRI was performed at selected intervals thereafter. In all cases, a clinical grading system was used to assess the severity of inflammation before imaging. In a dose-response experiment, total vitreous protein was measured from vitreous specimens obtained 1 day after endotoxin injection and immediately after the imaging procedure. RESULTS: At 1 day after injection, endotoxin produced a selective breakdown of the inner BRB at all doses evaluated (0.01 microgram to 500 micrograms). Permeability-surface area product normalized to the area of leaky retina (PS') increased from 1.35 +/- 0.78 x 10(-4) cm/minute (mean +/- SEM, n = 4 eyes) at a dose of 0.01 microgram to 8.15 +/- 2.22 x 10(-4) cm/minute n = 4) eyes) at a dose of 10 micrograms. Inner BRB integrity was restored by day 28 after injection. In general, changes in PS', blood-aqueous barrier leakage, mean clinical score, and vitreous protein concentration were found, but the correlation between any two of these parameters was poor. CONCLUSION: Leakage of contrast appears early in the course of endotoxin-induced endophthalmitis and is a self-limited process. In future studies, these quantifiable changes in BRB permeability should prove useful in the assessment of various therapeutic interventions.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
A. L. Moyer, R. T. Ramadan, J. Thurman, A. Burroughs, and M. C. Callegan
Bacillus cereus Induces Permeability of an In Vitro Blood-Retina Barrier
Infect. Immun., April 1, 2008; 76(4): 1358 - 1367.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Luan, R. Roberts, M. Sniegowski, D. J. Goebel, and B. A. Berkowitz
Retinal Thickness and Subnormal Retinal Oxygenation Response in Experimental Diabetic Retinopathy
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 320 - 328.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. A. Berkowitz, R. Roberts, H. Luan, J. Peysakhov, X. Mao, and K. A. Thomas
Dynamic Contrast-Enhanced MRI Measurements of Passive Permeability through Blood Retinal Barrier in Diabetic Rats
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2391 - 2398.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. C. Callegan, M. Engelbert, D. W. Parke II, B. D. Jett, and M. S. Gilmore
Bacterial Endophthalmitis: Epidemiology, Therapeutics, and Bacterium-Host Interactions
Clin. Microbiol. Rev., January 1, 2002; 15(1): 111 - 124.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T. Das, S. Jalali, V. K Gothwal, S. Sharma, and T. J Naduvilath
Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study
Br. J. Ophthalmol., September 1, 1999; 83(9): 1050 - 1055.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the Association for Research in Vision and Ophthalmology